Abstract
Carbapenem-resistant Klebsiella pneumoniae are distributed worldwide. This study aimed to characterize a hypervirulent tigecycline-resistant and carbapenem-resistant Klebsiella pneumoniae strain, XJ-K2, collected from a patient’s blood. We tested antimicrobial susceptibility, virulence, and whole-genome sequencing (WGS) on strain XJ-K2. WGS data were used to identify virulence and resistance genes and to perform multilocus sequence typing (MLST) and phylogenetic analysis. Three novel plasmids, including a pLVPK-like virulence plasmid (pXJ-K2-p1) and two multiple resistance plasmids (pXJ-K2-KPC-2 and pXJ-K2-p3), were discovered in strain XJ-K2. The IncFII(pCRY) plasmid pXJ-K2-p3 carried the dfrA14, sul2, qnrS1, blaLAP-2, and tet(A) resistance genes. The IncFII(pHN7A8)/IncR plasmid pXJ-K2-KPC-2 also carried a range of resistance elements, containing rmtB, blaKPC-2, blaTEM-1, blaCTX-M-65, and fosA3. MLST analysis revealed that strain XJ-K2 belonged to sequence type 11 (ST11). Seven complete phage sequences and many virulence genes were found in strain XJ-K2. Meanwhile, antimicrobial susceptibility tests and G. mellonella larval infection models confirmed the extensively drug resistance (XDR) and hypervirulence of KJ-K2. To our knowledge, this is the first observation and description of the ST11 hypervirulent tigecycline- and carbapenem-resistant K. pneumoniae strain co-carrying blaKPC-2 and the tet(A) in a patient’s blood in China. Further investigation is needed to understand the resistance and virulence mechanisms of this significant hypervirulent tigecycline- and carbapenem-resistant strain.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Klebsiella pneumoniae is a common Gram-negative opportunistic pathogen that causes multiple diseases, including pneumonia, bacteremia, liver abscess, and urinary tract infections [1]. Carbapenem-resistant K. pneumoniae (CRKP) and hypervirulent K. pneumoniae (hvKP) have emerged as the two major types of clinically significant pathogens in China [2]. CRKP is commonly resistant to multiple antibiotics, including carbapenems, quinolones, and aminoglycosides [3]. These widespread CRKP isolates represent an antibiotic resistance threat of the highest priority, limiting therapeutic options for these multidrug resistance strains [4]. In China, the most common clinical CRKP isolates belong to sequence type (ST) 11, considered the most infectious clone responsible for the increasing prevalence of CRKP [5].
HvKP is associated with high morbidity and mortality because it causes life-threatening and community-acquired infections, including liver abscesses, endophthalmitis, pneumonia, and meningitis in healthy individuals [6]. HvKP was first reported in Taiwan in the mid-1980s and 1990s [7]. In the decades since then, hvKP has been reported globally [8]. These hypervirulent strains have a hypermucoviscous phenotype that is detectable as a positive “string test” result and a hypervirulent phenotype that is attributable to the presence of a large pLVPK-like virulence plasmid, harboring two capsular polysaccharide (CPS) regulator genes (rmpA and rmpA2) and several siderophore gene clusters [6].
Most hvKP strains are susceptible to commonly used antibacterial agents except ampicillin [9]. Recent studies have shown that hvKP strains can acquire a carbapenemase-encoding plasmid to transform into carbapenem-resistant hvKP (CR-hvKP) strains, and CRKP strains can evolve to become CR-hvKP strains by acquiring a pLVPK-like virulence plasmid [10]. These strains have made clinical treatment and infection control more difficult because they are simultaneously multidrug-resistant, hypervirulent, and highly transmissible [11]. Due to the emergence of CRKP strains, tigecycline was considered as a last-resort treatment for CRKP infections [12]. In recent years, however, some tigecycline- and carbapenem-resistant K. pneumoniae (TCRKP) have been reported, which has further limited the concern with respect to therapeutic selection [13]. However, until now, the mechanisms underlying K. pneumoniae’s resistance to tigecycline have not been fully understood. Previous studies showed that overexpression of the efflux pumps and alteration in the tigecycline target site played important roles in mediating tigecycline resistance [14].
In addition, recent research indicated that deletion of ramR and tet(A) is associated with resistance to tigecycline in K. pneumoniae [13]. Although Gu et al. reported the emergence of blaKPC-2 and the tet(A) in the ST11 hypervirulent TCRKP isolated from a patient’s gut, the occurrence of a TCRKP strain with these characteristics in a patient’s blood has not previously been reported [15]. This study reports a hypervirulent TCRKP strain, strain XJ-K2, isolated from a patient’s blood in China. To our knowledge, this is the first report of the ST11 hypervirulent tigecycline- and carbapenem-resistant K. pneumoniae strain co-carrying blaKPC-2 and tet(A) plasmids that have been detected in patient blood in China.
Materials and methods
Bacterial strain
In May 2018, K. pneumoniae strain XJ-K2 was isolated from a blood sample collected from a patient at a teaching hospital in Shanghai, China.
Antimicrobial susceptibility testing
The broth microdilution method was used to determine the minimum inhibitory concentration (MIC) values of 27 antimicrobial agents. The positive control well (without antibiotics) showed significant bacterial growth and the MIC values could be read. The MICs were interpreted following the Clinical and Laboratory Standards Institute (CLSI, 2018). As there are no CLSI breakpoints for tigecycline and colistin, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) followed the MIC interpretation. Escherichia coli ATCC 25,922 was used as quality control strain for antimicrobial susceptibility testing.
Virulence testing for hypervirulent K. pneumoniae strain XJ-K2
A hypermucoviscous phenotype was determined using the string test previously described [6]. The Galleria mellonella (G. mellonella) model was used to evaluate the virulence of K. pneumoniae strains [3]. G. mellonella larvae (~ 300 mg; Tianjin Huiyude Biotech Company, Tianjin, China) were used to test the virulence of the strain XJ-K2. Each group selected ten randomly selected insects weighing 250–350 mg. Overnight cultures of strains XJ-K2, WCHKP030925 (hypervirulent control), and WCHKP13F4 (low virulence control) were washed with phosphate-buffered saline (PBS) and further adjusted with PBS to concentrations of 1 × 105, 1 × 106, and 1 × 107 CFU/ml [16]. Ten microliters of inoculum was injected into G. mellonella larvae through the last left pro-leg, followed by incubation at 37 ℃ in darkness [3]. The number of dead larvae was counted at 12-h intervals up to 72 h after the incubation.
WGS and bioinformatics analysis
Illumina HiSeq 4000 and the PacBio RS II platform were used to sequence the genome of strain XJ-K2 at the Beijing Genomics Institute. The program Pbdagcon (https://github.com/PacificBiosciences/pbdagcon) was used for self-correction [17]. Draft genomic unitigs were assembled using the Celera Assembler against a high-quality corrected circular consensus sequence subreads set [18]. GATK (https://www.broadinstitute.org/gatk/) and SOAP tool packages were used to make single-base corrections [19]. RAST 2.0 (https://rast.nmpdr.org/), Prokka (http://vicbioinformatics.com/), and BLASTN (https://www.ncbi.nlm.nih.gov/) were used to annotate the genome sequence of strain XJ-K2. ORFfinder (https://www.ncbi.nlm.nih.gov/orffinder/) was used to predict the open reading frames (ORFs). Annotation of mobile elements, drug resistance genes, and other characteristic features was performed by ISfinder, Resfinder 3.1, and INTEGRALL. For the classification of plasmids, PlasmidFinder 2.0 was used [20]. The MLST of Klebsiella pneumoniae strain XJ-K2 was performed using MLST 2.0 (https://cge.cbs.dtu.dk/services/MLST/). A comparative plasmid map was generated by the BLAST Ring Image Generator (BRIG). Gene comparative structure diagrams were created in Easyfig. The nucleotide sequence accession numbers for K. pneumoniae strain XJ-K2 in GenBank are CP032240 (chromosome), CP032241 (pXJ-K2-p1), CP032242 (pXJ-K2-KPC-2), and CP032243 (pXJ-K2-p3).
Phylogenetic analysis
In this study, Unipro UGENE 1.32 (http://ugene.net/) was used to perform phylogenetic analysis. We selected the genome sequences of representative K. pneumoniae strains that carry a pLVPK-like virulence plasmid to construct a phylogenetic tree for K. pneumoniae strain XJ-K2.
Results
Isolation of a hypermucoviscous multiresistant K. pneumoniae strain
Klebsiella pneumoniae XJ-K2 was isolated from the Intensive Care Unit (ICU) of Huashan Hospital of Fudan University in Shanghai in May 2018. It was derived from a blood sample of a patient. The patient was admitted to the ICU with cerebral hemorrhage and was treated with indwelling catheterization. The urinary tract infection combined with bacteremia could be a risk factor for the patient’s poor prognosis. Antimicrobial susceptibility testing showed that strain XJ-K2 was extensively drug-resistant (XDR). Therefore, the patient was treated with polymyxin B 120 mg/day. After 1-week follow-up, no obvious abnormalities were found in the blood culture, and clinical symptoms were obviously improved. XDR-K. pneumoniae is considered a huge health concern due to the few treatment options available in the clinic. XJ-K2 was determined as a hypermucoviscous strain by the “string test.” Hypermucoviscous K. pneumoniae was diagnosed by a positive string test (> 5 mm) [6].
The G. mellonella model was used to evaluate the virulence of K. pneumoniae strains in vivo. G. mellonella was infected by K. pneumoniae strains through exposure to inoculum concentrations of 1 × 107 CFU/ml for 48 h, and the survival rates of G. mellonella infected by strains XJ-K2, WCHKP030925, and WCHKP13F4 were 0.0%, 10.0%, and 60%, respectively (Fig. 1). Based on these results, strain XJ-K2 was identified as hypervirulent K. pneumoniae.
The broth microdilution method was used to determine the minimum inhibitory concentration (MIC) of 27 antimicrobial agents. The results showed that strain XJ-K2 was extensively drug-resistant (XDR), and high-level resistance was observed against broad-spectrum cephalosporins, aminoglycosides, fosfomycin, and folate pathway inhibitors (Table 1). Of note, MIC > 2 μg/ml of polymyxin B in K. pneumoniae was regarded as being resistant to polymyxin B according to EUCAST. In this study, the MIC of polymyxin B was 2 μg/ml, close to the critical value of polymyxin B resistance, which might be a potential threat to clinical treatment.
Genome features and chromosome analysis
The results of our analysis showed that the genome of strain XJ-K2 contains a chromosome (5,503,278 bp) and three plasmids: pXJ-K2-p1 (219,775 bp), pXJ-K2-KPC-2 (96,030 bp), and pXJ-K2-p3 (84,855 bp; Table 2). The final draft genome revealed that the strain XJ-K2 chromosome contains 57.31% G + C content and 5715 predicted ORFs. Twelve antibiotic resistance genes were identified in strain XJ-K2, and the resistance genes fosA, mdf(A), and blaSHV-182 were located on the chromosome. Furthermore, among genes located on the strain XJ-K2 chromosome, gyrA had two sites with amino acid mutations (Ser83Ile and Asp87Gly) and parC had one (Ser80Ile) [21]; these mutations are associated with quinolone resistance. The strain XJ-K2 carried four genes encoding β-lactamases, one of which was a carbapenemase gene (blaKPC-2; Table 3). Our analysis showed that strain XJ-K2 had several virulence factors, including the regulators of capsular polysaccharides (rmpA and rmpA2), the type 1 fimbriae fimbriae-encoding system (fimABCDEFGHIK), the type 3 fimbriae-encoding system (mrkABCDF), aerobactin (iucABCD and iutA), and yersiniabactin (fyuA, irp1, irp2, and ybtAEPQSTUX). MLST analysis showed that strain XJ-K2 belonged to sequence type 11. The phylogenetic analysis showed that the ST11 hvKP strain XJ-K2 was highly similar to the hvKP strain XJ-K1 (Fig. 2). Furthermore, seven complete phage sequences, ranging in size from 37.5 to 59.6 kb, were found in strain XJ-K2 (Table 4).
Sequence analysis of two multidrug-resistant plasmids
In this study, the plasmids harboring blaKPC-2 and the tet(A) were designated pXJ-K2-KPC-2 and pXJ-K2-p3, respectively. Plasmids pXJ-K2-KPC-2 and pXJ-K2-p3 belonged to the IncFII(pHN7A8)/IncR and IncFII(pCRY) groups. Both plasmids contained genes conferred antibiotic resistance, conjugal transfer, replication, and stability.
Sequence alignments using BLASTN showed that pXJ-K2-KPC-2 shared 79% query coverage and 99% identity with plasmid unnamed3, as described in our previous report (GenBank accession number CP032166). The resistance region of pXJ-K2-KPC-2 contained three resistance units (IS26-ΔISEcp1-blaCTX-M-65-IS903B, IS26-fosA3-IS26-ΔIS1294-blaTEM-1-rmtB1-IS26, and IS26-ΔISkpn6-blaKPC-2-ISkpn27-IS26) (Fig. 3). The three resistance units conferred resistance to aminoglycoside, carbapenems, β-lactam, and fosfomycin.
The plasmid pXJ-K2-p3 was highly similar (100% query coverage, 99.97% identity) to the plasmid p4-L388 (GenBank accession number CP029223). These plasmids harbored two resistance modules, namely, the dfrA14 region and the tet(A) region (Fig. 4). The dfrA14 region consisted of two resistance units, IS26-IntI1-dfrA14-IS26 and ISVsa3-sul2-IS5075. Resistance gene dfrA14 was located within a gene cassette related to In191 (Table 3). Moreover, the tet(A) region contained the resistance genes qnrS1, blaLAP-2, and tet(A), which conferred resistance to quinolone, β-lactam, and tigecycline.
Sequence analysis of the pLVPK-like virulence plasmid
The IncHI1B plasmid pXJ-K2-p1 (50.02% G + C content, 253 ORFs) was a virulence plasmid that contained the hvKP-associated virulence genes iucABCD, rmpA, rmpA2, and iutA. Nevertheless, no antibiotic-resistance genes were found on pXJ-K2-p1. Sequence alignments revealed that pXJ-K2-p1 exhibited 90% query coverage and 99.06% identity with the typical virulence plasmid pLVPK (GenBank accession number AY378100). Therefore, pXJ-K2-p1 was considered to be a pLVPK-like virulence plasmid. To understand the difference in virulence genes between the pXJ-K2-p1 and pLVPK virulence plasmids, we constructed a comparative plasmid map, comparing the typical virulence plasmid pLVPK (AY378100) with the plasmid pXJ-K2-p1 using BLAST Ring Image Generator (Fig. 5). As shown in Fig. 5, genes iroBCD, fecA, fecR, and fecl were deleted in the pXJ-K2-p1 plasmid.
Discussion
CR-hvKP strains have been identified in multiple sequence types, including ST23, ST11, ST36, and ST65 [22]. Gu et al. reported that some ST11 CRKP strains transform into CR-hvKP by obtaining a pLVPK-like virulence plasmid [10]. In addition, Liu et al. reported that ST23 CR-hvKP emerged following its acquisition of carbapenemase plasmids [23], suggesting that the horizontal transfer of virulence plasmids into CRKP strains and carbapenemase plasmids into hvKP strains has substantially contributed to the emergence of multiple sequence types of CR-hvKP. In this study, strain XJ-K2 was resistant to tigecycline, meropenem, and imipenem (Table 1), which suggests that strain XJ-K2 is a TCRKP. The ST11 hypervirulent TCRKP strain XJ-K2 revealed two typical features of hvKP, i.e., a hypermucoviscous phenotype and a pLVPK-like virulence plasmid encoding the virulence genes rmpA, rmpA2, iucABCD, and iutA. Hypervirulent TCRKP in patient blood limits therapeutic options and poses a huge threat to public health. Analysis of its genome sequence revealed that multiple resistance determinants (MDRs) were present in the ST11 hypervirulent TCRKP strain (Table 4), which is the first report of the first time that an ST11 hypervirulent TCRKP strain co-producing blaKPC-2 and the tet(A) has been isolated from patient blood in China.
Phylogenetic analysis of strain XJ-K2 revealed that it is closely related to strain XJ-K1 (CP032163, ST11 and Shanghai, China), suggesting that they share a common ancestor. One virulence plasmid (pXJ-K2-p1) and two MDR plasmids (pXJ-K2-KPC-2 and pXJ-K2-p3) were identified in the hypervirulent TCRKP strain XJ-K2. The plasmid pXJ-K2-p1 was highly similar to the typical virulence plasmid pLVPK, which was found in hvKP strain CG43. These two plasmids carried aerobactin-related genes (iucABCD and iutA) and capsular polysaccharide regulator genes (rmpA and rmpA2), which are characteristic features of hvKP [24]. Many virulence genes might have helped this strain to grow and replicate during host infection.
The MDR plasmid pXJ-K2-KPC-2 was similar to the plasmid unnamed3 (GenBank accession number CP032166). These two plasmids possessed IncFII(pHN7A8)/IncR backbones. Unlike the plasmid unnamed3’s resistance regions, the resistance unit IS26-blaSHV-12-ΔTnAs1 was absent in pXJ-K2-KPC-2. These results indicated that plasmids with similar backbones could carry different resistance determinants that effectively confer resistance. In pXJ-K2-KPC-2, blaKPC-2 was associated with the IS26-based composite transposon, containing the ΔISKpn6-blaKPC-2-ISKpn27 core structure, which is the most common element in the genetic environment of blaKPC-2 in China [25].
The other MDR plasmid, pXJ-K2-p3, carried an IncFII(pCRY) backbone with five resistance determinants: dfrA14, sul2, qnrS1, blaLAP-2, and the tet(A). Furthermore, a total of seven complete phage sequences were detected in the strain XJ-K2 chromosome that contributed to the transfer of resistance genes and virulence factors [26]. As previously reported, there was a slight increase in the MIC value of tigatin in isolates carrying tet(A) [27]. Our study integrated the tet(A) was integrated into pXJ-K2-p3 via the insertion sequences IS26 and ΔTnAs1. The high mobility of IS26 could mediate the horizontal transmission of resistance genes or the functional deficiency of partial genes, which could be related to the genetic adaptation of plasmids under antibiotic pressure. Inserted tetA resulted in low levels of tigecycline resistance, which may be related to efflux mechanisms [28]. Interestingly, ramR gene was found on the chromosome of the XJ-K2 strain, which might be meaningful regarding increased resistance. Therefore, we speculated that K. pneumoniae carrying ramR and tet(A) tended to evolve tigecycline resistance under selective pressure more easily. However, it remains unknown whether tet(A) played a major role in tigecycline resistance, which needs further study. In191, from the dfrA14 region, IntI1, and dfrA14 were integrated into the plasmid via insertion sequence IS26. In the plasmid pKF3-140 [29], class 1 integron harbored three resistance genes, specifically dfrA17, aadA5, and sul1, which are associated with resistance to trimethoprim, aminoglycoside, and sulfonamide, suggesting that class 1 integron is vital in increasing multidrug resistance among bacterial strains [30].
Conclusion
In conclusion, we have reported an ST11 hypervirulent TCRKP strain, XJ-K2, isolated from patient blood. We characterized the genomic features of strain XJ-K2 via WGS and bioinformatic analysis. To our best knowledge, this is the first report of the ST11 hypervirulent TCRKP strain co-carrying blaKPC-2 and the tet(A) has been isolated from patient blood in China. In addition, we should be devoted to concerning the spread of tet(A) and ramR in K. pneumoniae clinical isolates, which may be potential threats leading to tigecycline resistance. Therefore, active surveillance of this and other hypervirulent TCRKP strains and the development of new drugs are required to control the growth of these strains and prevent their transmission in hospitals.
Data Availability
We have uploaded the sequencing data of the article to the repository (https://www.ncbi.nlm.nih.gov/). Additional data are presented in this manuscript in the main text.
References
Navon-Venezia S, Kondratyeva K, Carattoli A (2017) Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev 41:252–275
Dong N, Lin D, Zhang R, Chan EW, Chen S (2018) Carriage of blakpc-2 by a virulence plasmid in hypervirulent Klebsiella pneumoniae. J Antimicrob Chemother 73:3317–3321
Feng Y, Lu Y, Yao Z, Zong Z (2018) Carbapenem-resistant hypervirulent Klebsiella pneumoniae of sequence type 36. Antimicrob Agents Chemother 62(7):e02644–17
Han JH, Lapp Z, Bushman F, Lautenbach E, Goldstein EJC, Mattei L, Hofstaedter CE, Kim D, Nachamkin I, Garrigan C et al (2019) Whole-genome sequencing to identify drivers of carbapenem-resistant Klebsiella pneumoniae transmission within and between regional long-term acute-care hospitals. Antimicrob Agents Chemother 63(11):e01622–19
Zhang R, Liu L, Zhou H, Chan EW, Li J, Fang Y, Li Y, Liao K, Chen S (2017) Nationwide surveillance of clinical carbapenem-resistant Enterobacteriaceae (CRE) strains in China. EBioMedicine 19:98–106
Shon AS, Bajwa RP, Russo TA (2013) Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 4:107–118
Cheng DL, Liu YC, Yen MY, Liu CY, Wang RS (1991) Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients. Archives of internal medicine 151:1557–1559
Catalán-Nájera JC, Garza-Ramos U, Barrios-Camacho H (2017) Hypervirulence and hypermucoviscosity: two different but complementary Klebsiella spp Phenotypes? Virulence 8:1111–1123
Xu M, Fu Y, Fang Y, Xu H, Kong H, Liu Y, Chen Y, Li L (2019) High prevalence of kpc-2-producing hypervirulent Klebsiella pneumoniae causing meningitis in eastern China. Infect Drug Resist 12:641–653
Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L, Chan EW, Shu L, Yu J, Zhang R et al (2018) A fatal outbreak of st11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a chinese hospital: a molecular epidemiological study. Lancet Infect Dis 18:37–46
Chen L, Kreiswirth BN (2018) Convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae. Lancet Infect Dis 18:2–3
Dubrovskaya Y, Chen TY, Scipione MR, Esaian D, Phillips MS, Papadopoulos J, Mehta SA (2013) Risk factors for treatment failure of polymyxin b monotherapy for carbapenem-resistant Klebsiella pneumoniae infections. Antimicrob Agents Chemother 57:5394–5397
Chiu SK, Huang LY, Chen H, Tsai YK, Liou CH, Lin JC, Siu LK, Chang FY, Yeh KM (2017) Roles of ramR and tet(A) mutations in conferring tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae clinical isolates. Antimicrob Agents Chemother 61(8):e00391–17
Ovejero CM, Escudero JA, Thomas-Lopez D, Hoefer A, Moyano G, Montero N, Martin-Espada C, Gonzalez-Zorn B (2017) Highly tigecycline-resistant Klebsiella pneumoniae sequence type 11 (st11) and st147 isolates from companion animals. Antimicrob Agents Chemother 61(6):e02640–16
Gu D, Lv H, Sun Q, Shu L, Zhang R (2018) Emergence of tet(A) and bla(kpc-2) co-carrying plasmid from a ST11 hypervirulent Klebsiella pneumoniae isolate in patient’s gut. Int J Antimicrob Agents 52:307–308
Zhu X, Sun C, Chen H, Zhan X, Liu C, Liu X, Yue C, Song H, Lu H, Jia X (2020) Co-occurrence of three different plasmids in an extensively drug-resistant hypervirulent Klebsiella pneumoniae isolate causing urinary tract infection. J Global Antimicrob Resist 23:203–210
Chin CS, Alexander DH, Marks P, Klammer AA, Drake J, Heiner C, Clum A, Copeland A, Huddleston J, Eichler EE et al (2013) Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods 10:563–569
Berlin K, Koren S, Chin CS, Drake JP, Landolin JM, Phillippy AM (2015) Assembling large genomes with single-molecule sequencing and locality-sensitive hashing. Nat Biotechnol 33:623–630
O’Rawe J, Jiang T, Sun G, Wu Y, Wang W, Hu J, Bodily P, Tian L, Hakonarson H, Johnson WE et al (2013) Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing. Genome Med 5:28
Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O, Villa L, Møller Aarestrup F, Hasman H (2014) In silico detection and typing of plasmids using plasmidfinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother 58:3895–3903
Al-Marzooq F, MohdYusof MY, Tay ST (2014) Molecular analysis of ciprofloxacin resistance mechanisms in Malaysian ESBL-producing Klebsiella pneumoniae isolates and development of mismatch amplification mutation assays (MAMA) for rapid detection of gyrA and parC mutations. BioMed Res Int 2014:601630
Dong N, Sun Q, Huang Y, Shu L, Ye L, Zhang R, Chen S (2019) Evolution of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae by acquisition of bla(vim-1)-bearing plasmid. Antimicrob Agents Chemother 63(9):e01056–19
Liu Y, Long D, Xiang TX, Du FL, Wei DD, Wan LG, Deng Q, Cao XW, Zhang W (2019) Whole genome assembly and functional portrait of hypervirulent extensively drug-resistant NDM-1 and KPC-2 co-producing Klebsiella pneumoniae of capsular serotype K2 and ST86. J Antimicrob Chemother 74:1233–1240
Russo TA, Olson R, Fang CT, Stoesser N, Miller M, MacDonald U, Hutson A, Barker JH, La Hoz RM, Johnson JR (2018) Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol 56(9):e00776–18
Wang L, Fang H, Feng J, Yin Z, Xie X, Zhu X, Wang J, Chen W, Yang R, Du H et al (2015) Complete sequences of KPC-2-encoding plasmid p628-KPC and CTX-M-55-encoding p628-CTXM coexisted in Klebsiella pneumoniae. Front Microbiol 6:838
Salloum T, Arabaghian H, Alousi S, Abboud E, Tokajian S (2017) Genome sequencing and comparative analysis of an NDM-1-producing Klebsiella pneumoniae ST15 isolated from a refugee patient. Pathog Global Health 111:166–175
Linkevicius M, Sandegren L, Andersson DI (2016) Potential of tetracycline resistance proteins to evolve tigecycline resistance. Antimicrob Agents Chemother 60:789–796
Sheng Z-K, Hu F, Wang W, Guo Q, Chen Z, Xu X, Zhu D, Wang M (2014) Mechanisms of tigecycline resistance among Klebsiella pneumoniae clinical isolates. Antimicrob Agents Chemother 58:6982–6985
Zhao F, Bai J, Wu J, Liu J, Zhou M, Xia S, Wang S, Yao X, Yi H, Lin M et al (2010) Sequencing and genetic variation of multidrug resistance plasmids in Klebsiella pneumoniae. PLoS ONE 5:e10141
Escudero JA, Loot C, Parissi V, Nivina A, Bouchier C, Mazel D (2016) Unmasking the ancestral activity of integron integrases reveals a smooth evolutionary transition during functional innovation. Nat Commun 7:10937
Acknowledgements
We are very grateful to Huashan Hospital of Fudan University in Shanghai for giving us the XJ-K2 strain.
Funding
This work was supported by grants from Chinese National Natural Science Foundation (Grant No. 31870135) and the “1000 Talent Plan” of Sichuan Province Program (Grant No. 980).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation and strains collection were performed by Xiaokui Zhu, Lingjie Song, Huiming Yuan, Chuanyu Sun and Huaixin Geng. Data analysis was performed by Changwu Yue, Xu Jia, Xianqin Zhang and Guangxin Luan. The first draft of the manuscript was written by Xiaokui Zhu and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Conflicts of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhu, X., Yue, C., Geng, H. et al. Coexistence of tet(A) and blaKPC-2 in the ST11 hypervirulent tigecycline- and carbapenem-resistant Klebsiella pneumoniae isolated from a blood sample. Eur J Clin Microbiol Infect Dis 42, 23–31 (2023). https://doi.org/10.1007/s10096-022-04512-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-022-04512-6